Abnova Taiwan Corp. engages in researching, developing, manufacturing and selling antibodies. It also supplies medicines and human genes albumen. Its products include antibodies for virus, microbial, neuroscience and others. It operates through the following geographical segments: Taiwan, America, England, China, Japan, Germany, and Other Country. The company was founded on January 4, 2002 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company